News
LABT ▲ +8.6% - Lakewood-Amedex Biotherapeutics, Inc.
LABT ▲ +8.6% - Lakewood-Amedex Biotherapeutics, Inc.
$LABT LABT - Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026
21-OCT-2026 08:02 AM ET
Share this post
More filings for $LABT
LABT ▼ -6.9% - Lakewood-Amedex Biotherapeutics, Inc.Oct 7, 2026LABT ▼ -5.3% - Lakewood-Amedex Biotherapeutics, Inc.Oct 1, 2026LABT ▲ +99.4% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026LABT ▲ +88.0% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026LABT ▲ +10.6% - Lakewood-Amedex Biotherapeutics, Inc.Sep 24, 2026LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc.Sep 21, 2026
View full $LABT filing history →💬 Comments
Loading comments…
Leave a comment